Session Details
[28P-pm]Analytical Chemistry, Biophysics
Fri. Mar 28, 2025 1:30 PM - 5:00 PM JST
Fri. Mar 28, 2025 4:30 AM - 8:00 AM UTC
Fri. Mar 28, 2025 4:30 AM - 8:00 AM UTC
Poster (MARINE MESSE FUKUOKA Hall B: Exhibition Room [1F])
[28P-pm101S]Analysis of endocan-derived glycosaminoglycans in human breast cancer cell line culture medium using HPLC with fluorescence detection
○Naoko Ohtaka1, Shinnosuke Tanaka1, Kazuki Tsukuda1, Takamasa Ishii1, Yiyun Xie1, Rie Itou1, Yusuke Iwasaki1, Yoshinori Kato1, Hiroshi Akiyama1,2 (1. Hoshi Univ, 2. NIHS)
[28P-pm102S]Analysis of glycosaminoglycan in the kidney of cisplatin-induced rat renal fibrosis model using HPLC with fluorescence detection
○Shinnosuke Tanaka1, Naoko Ootaka1, Kazuki Tsukuda1, Takamasa Ishii1, Yusuke Iwasaki1, Rie Ito1, Kouhei Matsushita2, Yuji Ishii2, Hiroshi Akiyama1,2 (1. Hoshi Univ., 2. NIHS)
[28P-pm103S]Selective HPLC determination of malondialdehyde in human plasma by excimer-fluorescence derivatization method
○Naofumi Yoshida1, Mashiro Etoh1, Naho Kato1, Reiko Koga1, Hideyuki Yoshida1, Hitoshi Nohta1 (1. Fac. Pharm. Sci., Fukuoka Univ.)
[28P-pm104S]Analysis of free amino acids in honey from Japanese honey bees using a multidimensional chiral HPLC system
○Mayu Yoshinaga1, Reiko Koga1, Naho Kato1, Masashi Mita2, Kenji Hamase3, Hideyuki Yoshida1, Hitoshi Nohta1 (1. Fac.Pharm. Sci., Fukuoka Univ., 2. KAGAMI, Inc., 3. Grad. Sch. Pharm. Sci., Kyushu Univ.)
[28P-pm105S]Development of solid-phase supported fluorescent reagents for amines
○Reo Ishimoto1, Miyu Nomiyama1, Reiko Koga1, Naho Kato1, Hideyuki Yoshida1, Hitoshi Nohta1 (1. Fac.Pharm. Sci., Fukuoka Univ.)
[28P-pm106S]Selective HPLC Determination of Carboxylic Acids in the TCA Cycle by Excimer Fluorescence Derivatization Method
○Nanase Yamaguchi1, Reiko Koga1, Naho Kato1, Hideyuki Yoshida1, Hitoshi Nohta1 (1. Fac. Pharm. Sci., Fukuoka Univ.)
[28P-pm107S]Development of a multidimensional chiral HPLC system for the highly selective determination of histidine and 1-methylhistidine
○Kyoka Yamaguchi1, Reiko Koga1, Naho Kato1, Masashi Mita2, Kenji Hamase3, Hideyuki Yoshida1, Hitoshi Nohta1 (1. Fac. Pharm. Sci., Fukuoka Univ., 2. KAGAMI, Inc., 3. Grad. Sch. Pharm. Sci., Kyushu Univ.)
[28P-pm108S]HPLC analysis of DL-aspartic acid in leukemic cell lines using chiral fluorescence derivatization reagent
○Miku Haraguchi1, Naho Kato1, Reiko Koga1, Hideyuki Yoshida1, Hitoshi Nohta1 (1. Fac. Pharm. Sci., Fukuoka Univ.)
[28P-pm109]Investigation of molecular recognition mechanism of molecularly imprinted polymers for warfarin and its derivatives
○Chie Honda1, Jun Haginaka2 (1. Sch. Pharm. Pharmaceut. Sci., Mukogawa Womens' Univ., 2. Res. Inst. Hlth. Sci., Mukogawa Women's Univ.)
[28P-pm110]Separation of long chain plasmid DNA pHelper isoforms by anion-exchange chromatography
○Mengfan Wang1, Yoshimi Hashimoto1, Seiji Ito1 (1. Tosoh Corporation)
[28P-pm111]Separation behavior of cacao polyphenols, tea catechins etc. in reverse phase HPLC, and application to assay of these ingredients in high cacao chocolate and green tea beverages
○Hiroyuki Nishi1, Haruka Koike1, Momoka Ueda1, Ayaka Kimoto1, Kohei Kawabata1 (1. Faculty of Pharmacy, Yasuda Womens' Univ.)
[28P-pm112]Anion exchange-HPLC Method for Evaluating the Encapsulation Efficiency of mRNA-Loaded Lipid Nanoparticles Using Analytical Quality by Design
○Shoki Hara1, Shuntaro Arase1, Syusuke Sano1, Takuya Suzuki1, Iori Mizogaki1, Shinya Sato1, Koji Ukai1 (1. Formulation Research, Eisai Co. Ltd.)
[28P-pm113]Pretreatment of the Catecholamines and their metabolites from biological samples using the solid phase extraction.
○yuko yui1, shigenori Ota1, Ken Kanno1 (1. GL Sciences Inc.)
[28P-pm114]Development of a method for quantifying impurities in a reagent using derivatization
○Kohei Okubo1, Chikako Konatsu1, Masaya Hashimoto2, Kazuhiko Shigeno2, Masanori Asai2, Tadashi Shimamura2, Yoshiki Tanaka1 (1. Taiho Pharmaceutical Co.,Ltd., Analytical Science, Chemistry, Discovery and Preclinical Research Division, 2. Taiho Pharmaceutical Co.,Ltd., Chemistry Section 3, Chemistry, Discovery and Preclinical Research Division)
[28P-pm115]Evaluation of flow vials for HPLC in gas-liquid reactions
○Takuji Shoda1, Ken Fujikawa1, Yosuke Demizu1, Tomoaki Sakamoto1 (1. Natl. Inst. Health Sci.)
[28P-pm116S]Development of HPLC-UV method for artificial polynucleotide molecules
○Nao Okabe1, Kouhei Kuba1, Yusuke Tanaka1, Kazumasa Zaima1, Naoki Harikai1 (1. Sch. Pharm., Nihon Univ.)
[28P-pm117]Development and evaluation of high stability silica column using hybrid silica
○Tomoyasu Tsukamoto1, Ryuji Koyama1, Norikazu Nagae1 (1. Chromanik Technologies)
[28P-pm118]Routine quantification and library matching for extractables and leachables testing using a UHPLC/UV/CAD/MS triple detector
○Mizuna Hamano1, Kyoko Fukushima1, Katherine Lovejoy2, Xiaochun Yu3, Carolin Kraus2, Basant Soliman2, Susanne Fabel2 (1. Thermo Fisher Scientific K.K., 2. Thermo Fisher Scientific, Germering, Germany, 3. PPD Laboratories, GMP Labs, a part of Thermo Fisher Scientific, Middleton, Wisconsin, USA)
[28P-pm119S]Synthesis of arylboronic acid precursors using solid-phase synthesis and its application to copper-mediated one-pot radioiodination
○Mamiko Tanaka1, Yuto Kondo2,1, Hiroyuki Kimura3,1, Yasunao Hattori1, Hidekazu Kawashima1, Kazuhiro Takahashi2, Hiroyuki Yasui1 (1. Kyoto Pharm. Univ. , 2. Fukushima Med. Univ., 3. Kanazawa Univ.)
[28P-pm120S]Development of an analytical method for lactate enantiomers using two-dimensional liquid chromatography
○Kazushi Mori1, Makoto Tsunoda1 (1. Sch. Pharm. Sci, The University of Tokyo)
[28P-pm121S]Comprehensive analysis of D/L-amino acids in deep sea water from Toyama Bay and its efficiency in anti-aging activity
○Haruto Iwata1, Airi Minami2, Reina Fujio1, Takahiro Takayama1, Koichi Inoue1,2 (1. Sch. Pharm. Sci., Ritsumei Univ., 2. Grad. Sch. Pharm. Sci., Ritsumei Univ.)
[28P-pm122]Comparison of charge profile and peptide map data of therapeutic monoclonal antibody
○Akira Harazono1, Hiroko Shibata1, Akiko Watabe Ishii1 (1. National Institute of Health Sciences)
[28P-pm123]Structural study of the TIFA/TIFAB heterodimer complex involved in the suppression of NF-κB signaling
Chiaki Ohyama1, Madoka Sakamoto1, Tsugumasa Toma2, Hiroshi Tateishi2, Mihoko Matsuo2, Mami Chirifu2, Shinji Ikemizu2, Hiroshi Morioka2, Mikako Fujita2, Jun-ichiro Inoue3, Yuriko Yamagata2,4, ○Teruya Nakamura2 (1. Sch. Pharm., Kumamoto Univ., 2. Grad. Sch. Pharm. Sci., Kumamoto Univ., 3. UTIAS, Univ. of Tokyo, 4. Shokei Univ.)
[28P-pm124S]Construction of NO radical-based Nanoparticles for MRI quantitative method of Ascorbic acid
○Naoko Iizuka1, Yuika Akizuki1, Tomohiro Umeno2, Kazuteru Usui1, Daisuke Yoshihara3, Tatsuya Naganuma4, Satoru Karasawa1 (1. Grad. Sch. Pharm. Sci., Showa Pharm. Univ., 2. Kyoto Pref. Uni. Med., 3. ISIT, 4. Japan REDOX.)
[28P-pm125S]Photodynamic Properties of Heavy-Atom-Free Photosensitizers Accumulated into Lipid Droplets
○Shota Matsumoto1, Tomohiro Umeno2, Kazuteru Usui1, Koichi Hamada1, Akihiro Mizutani1, Satoru Karasawa1 (1. Grad. Sch. Pharm. Sci., Showa Pharmaceutical Univ., 2. Kyoto Pref. Univ. Med.)
[28P-pm126S]Synthesis of Push-pull Pyridoqunoline Derivatives and Application for Bioimeging Probe
○Chihiro Kumasaka1, Moeka Fujihara1, Naoko Iizuka1, Shota Matsumoto1, Tomohiro Umeno2, Kazuteru Usui1, Satoru Karasawa1 (1. Grad. Sch. Pharm. Sci., Showa Pharmaceutical Univ., 2. Kyoto Pref. Univ. Med.)
[28P-pm127S]Thermodynamical modulation of fused in sarcoma phase separation with small cosolvents
○Keiji Kitamura1, Ayano Oshima1, Soichiro Kitazawa2, Ryo Kitahara1,2 (1. Grad. Sch. Pharm. Sci., Ritsumeikan Univ., 2. Col. Pharm., Ritsumeikan Univ.)
[28P-pm128S]Mechanisms of ATP-mediated suppression of fused in sarcoma liquid-liquid phase separation and aberrant aggregation
○Itta Tsukui1, Keiji Kitamura2, Miyu Arayama1, Ayano Oshima2, Soichiro Kitazawa1, Ryo Kitahara1,2 (1. College of Pharmaceutical Sciences, Ritsumeikan University, 2. Graduate School of Pharmacy, Ritsumeikan University)
[28P-pm129]Liquid-liquid phase separation and liquid-solid phase transition of RNA-binding protein FUS studied by pressure-jump turbidity measurements
○Yutaro Shiramasa1, Manato Morishita2, Fuka Sasaki1, Keiji Kitamura1, Ryo Kitahara1,2 (1. Grad. Sch. Pharm. Sci., Ritsumeikan Univ., 2. Coll. Pharm. Sci., Ritsumeikan Univ.)
[28P-pm130]The effect of side chain structure and amino acid composition on DNA condensation in cationic oligopeptides
○NEGI SHIGERU1, Tsuji Io1, Nakagawa Kawahara Yuka2, Tamura Akiko1, Takano Saki1 (1. Doshisha Women's College of Liberal Arts, 2. Kyoto University's Institute for Chemical Research)
[28P-pm131]Binding reaction of imidazoles to water-soluble non-planar iron (III) porphyrin complexes
○hirofumi konno1, Yasushi Kishimoto1 (1. Fac. Pharm. Sci., Teikyo Univ.)
[28P-pm132S]Affinity modification of a nanobody by framework region mutation integrating evolutionary engineering and informatics
○Ryohei Ozuru1, Kaiji Fujishima1, Kota Yamamoto1, Jumpei Tagawa1, Yuuki Koseki1, Haruya Yoshinaga1, Akinobu Senoo1, Saeko Yanaka1, Jose M.M. Caaveiro1 (1. Grad. Sch. Pharm. Sci., Kyushu Univ.)
[28P-pm133S]Measurement of relative intracellular potassium ion concentration changes using a simple ion meter
○Airi Nishi1, Takaya Iwamoto1, Ryuta Morinaga1, Koichi Kawada1, Kyosuke Uno1, Nobuyuki Kuramoto1 (1. Lab of Mol. Pharmacol., Fac. of Pharm. Sci., Setsunan Univ.)
[28P-pm134]Novel specific structural information of BRD9 for the drug development of synovial sarcoma.
○Tomoaki ISHIBA1, Riku Iwakiri2, Yuji Goma2, Yohei Miyanoiri3, Kenji Iwasaki1,2 (1. TARA, University of Tsukuba., 2. Grad. Sch. Sci. and Tech., University of Tsukuba., 3. IPR, Osaka Univ.)
[28P-pm135]Improvement of Expression of anti-P2X4Fab in Escherichia coli.
○yoshito abe1, Tadashi Ueda2 (1. Sch. Pharm. Fuk., IUHW, 2. Grad. Sch. Pharm. Sci., Kyushu Univ.)
[28P-pm136S]Structural Changes and Effects in Parkinson's Disease-Related Mutations of DJ-1
○Kazuma Yawata1, caaveiro jose1, saeko yanaka1, akinobu senoo1 (1. Grad. Sch. Pharm. Kyushu Univ.)
[28P-pm137S]Acquisition of X-dimer stabilized compounds of cell adhesion protein P-cadherin for development of inhibitors of cancer metastasis.
○Seiya Morikawa1, Akinobu Senoo1, Saeko Yanaka1, Caaveiro Jose1 (1. Grad. Sch. Pharm. Sci., Kyushu Univ.)
[28P-pm138S]Role of Cu(I) /Cu(II) binding materials in the inhibitory of monoamine oxidation
○Takumi Kurihara1, Masaaki Higuchi2, Saaya Uriu2, Minami Kaneko2, Takashi Miura1,2 (1. Grad.Sch.Pharm.Sci.,Int.Univ.Health and Welfare, 2. Dept.Pharm.Sci.,Int.Univ.Health and Welfare)
[28P-pm139S]Dry and wet analyses of changes in charge distribution and interactions caused by phosphorylation of intrinsically disordered regions
○Marin Kobashigawa1, Kazuhisa Ota1, Shinya Takazaki1 (1. Fac. of Pharm. Sci., Nagasaki Itn. Univ.)
[28P-pm140]Elucidation of the binding mode of the piperine/hPPARγ-LBD complex by X-ray crystallographic analysis
○Daichi Egawa1, Hiroaki Ishida2, Kazuaki Katakawa1 (1. Shonan Univ. Med. Sci., 2. Showa Pharm. Univ.)
[28P-pm141]Effects of cold atmospheric pressure plasma jet irradiation on cell membranes using lipid peroxidation and hemolysis as indicators.
○Tokuko Takajo1, Haruka Takada1, Ryota Yasuda1, kazunori Tsuchida1, Kazunori Anzai1 (1. Nihon Pharm.Univ.)
[28P-pm142S]Graphene modification by highly reactive functional groups for efficient Cryo-EM structure analysis
○Masayuki Fujimori1, Tsuyoshi Inoue1,2, Haruyasu Asahara1,2 (1. Grad. Sch. Pharm. Sci., Osaka Univ. , 2. OTRI, Osaka Univ.)
[28P-pm143S]Exploration of the molecular recognition mechanism and molecular design of chemically modified broadly neutralizing anti-HIV-1 antibodies.
○Hina Asakura1, Haruya Yoshinaga1, Saeko Yanaka1,2, Akinobu Senoo1, Rujas Edurne3,4, Nieva Jose Luis4, Jose M.M. Caaveiro 1 (1. Grad. Sch. Pharm. Sci., Kyushu Univ., 2. Excells, 3. Instituto Biofisika, University of the Basque Country, 4. Ikerbasque)
[28P-pm144]Quantification of oxygenation and oxygen consumption rates in the brain based on tissue oxygen level dependent (TOLD) MRI
Raj Kumar Parajuli1,2, Hiromi Sano3, Megumi Ueno4, Shan Gao3, Saaya Suzuki3, Akira Sumiyoshi3, Kensuke Osada3, Takayuki Obata3, Ichio Aoki3, ○Ken-ichiro Matsumoto4 (1. iQLS, QST, 2. Sydney Univ., 3. Inst. Quantum Med. Sci., QST, 4. NIRS, QST)
[28P-pm145]Novel OMRI method for detecting intraocular free radicals aiming at early diagnosis of diabetic retinopathy
○Ayano Enomoto1, Airi Ishibashi1, Kazuhiro Ichikawa1 (1. Fac. Pharm. Sci., Nagasaki International University)
[28P-pm146S]Development of an engineered protein shell disassembled by protein-protein interaction
○Makiyo Moritoki1, Eita Sasaki1,2, Kenjiro Hanaoka1,2 (1. Fac. Pharm., Keio Univ., 2. Grad. Sch. Pharm. Sci., Keio Univ.)
[28P-pm147S]Exploration of the effects of hinge modification of IgG1 on architecture and function.
○Yuuki Koseki1, Yuki Yamaguchi2, Michihiko Aoyama3, Minoru Tada3, Akinobu Senoo1, Akiko Ishii-Watabe3, Susumu Uchiyama2,4, Takayuki Uchihashi4,5, Koichi Kato4, Saeko Yanaka1,4, Jose M.M. Caaveiro1 (1. Grad. Sch. of Pharm. Sci., Kyushu Univ. , 2. Grad. Sch. of Eng., Osaka Univ. , 3. NIHS, 4. ExCELLS, 5. Grad. Sch. Sci., Nagoya Univ.)
[28P-pm148S]Molecular characterization of cadherin protein CDHR2/CDHR5 involved in inflammatory intestinal diseases
○Karin Fujishima1, Akinobu Senoo1, Saeko Yanaka1, Jose M.M. Caaveiro1 (1. Grad. Sch. Pharm. Sci., Kyushu Univ.)
[28P-pm149]Thermodynamic analysis of pH-dependent entropy effects on substrate binding of the multidrug efflux transporter, EmrE
○Kazumi Shimono1, Keisuke Matsuda2, Shoko Suzuki2, Daisuke Takahashi1, Shuichi Miyamoto1, Seiji Miyauchi2 (1. Fac. Pharm. Sci., Sojo Univ., 2. Fac. Pharm. Sci., Toho Univ.)
[28P-pm150]Physical properties of LDLs bound to recombinants of LDL related receptors were investigated by AFM
○Seiji Takeda1, Moeko Kitagawa1, Motokazu Furuno1, Kanako Ushirogata2, Takahisa Hiruma1, Agus Subagyo3, Taichi Takasuka2 (1. Fac. pharm. Sci., Hokkaido Univ. Sci., 2. Grad.Sch.GFR., Hokkaido Univ., 3. Grad.Sch.IST., Hokkaido Univ.)
[28P-pm151]Evaluation study of drug interactions of triterpenoid compounds with CYP3A4
○hirofumi tsujino1,2, Mikihiro Umabe3, Taku Yamashita4, Kazuo Harada1, Tsuyoshi Inoue1 (1. Grad. Sch. Pharm. Sci., Osaka Univ., 2. MuseumLinks, Osaka Univ., 3. Sch. Pharm. Sci., Osaka Univ., 4. Sch. Pharm. Sci., Mukogawa Women’s Univ.)
[28P-pm152S]CAH7 regulates the fatty acid chain length of membrane phospholipids.
○Ayano Ochi1, Kana Matsumoto1, Kohjiro Nagao1, Hiroyuki Saito1 (1. Kyoto Pharm. Univ.)
[28P-pm153]The effect of asparagine deamidation on the dimer interface of γS crystallin
○koichi kato1,2, Tomoki Nakayoshi2, Eiji Kurimoto2, Akifumi Oda2,3 (1. Pharm. Sci., Shonan Univ. of Med Sci., 2. Facul of Pharm., Meijo Univ., 3. Inst. Prot. Res., Osaka Univ.)
[28P-pm154]Cryo-electron microscopy structure of type IV pilus from enterotoxigenic Escherichia coli
○Kazuki Kawahara1,2, Hiroya Oki3, Ryuki Muramoto4, Minato Iimori1, Tomoya Imai5, Shigeaki Matsuda2,3, Tetsuya Iida2,3, Takuya Yoshida1, Takumi Ueda1, Shota Nakamura2,3 (1. Grad. Sch. Pharm. Sci., Osaka Univ., 2. CiDER, Osaka Univ., 3. RIMD, Osaka Univ., 4. Sch. Pham. Sci., Osaka Univ., 5. RISH, Kyoto Univ.)